Header Logo

Connection

JEFFREY ROSEN to Mice, Transgenic

Back to Details
This is a "connection" page, showing publications JEFFREY ROSEN has written about Mice, Transgenic.
JEFFREY ROSEN
Connection Strength
0.613
Mice, Transgenic
  1. WNT-Mediated Regulation of FOXO1 Constitutes a Critical Axis Maintaining Pubertal Mammary Stem Cell Homeostasis. Dev Cell. 2017 11 20; 43(4):436-448.e6.
    View in: PubMed
    Score: 0.084
  2. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells. 2013 Jan; 31(1):178-89.
    View in: PubMed
    Score: 0.060
  3. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007 Sep; 7(9):659-72.
    View in: PubMed
    Score: 0.042
  4. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol Endocrinol. 2007 Apr; 21(4):987-1000.
    View in: PubMed
    Score: 0.040
  5. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 2006 Jun 01; 66(11):5676-85.
    View in: PubMed
    Score: 0.038
  6. P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol. 2006 Jun; 20(6):1391-405.
    View in: PubMed
    Score: 0.037
  7. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice. J Biol Chem. 2005 Oct 28; 280(43):36301-9.
    View in: PubMed
    Score: 0.036
  8. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):191-204.
    View in: PubMed
    Score: 0.031
  9. A beta-catenin survival signal is required for normal lobular development in the mammary gland. J Cell Sci. 2003 Mar 15; 116(Pt 6):1137-49.
    View in: PubMed
    Score: 0.031
  10. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol. 2002 May 13; 157(4):703-14.
    View in: PubMed
    Score: 0.029
  11. A transgenic mouse model for mammary carcinogenesis. Oncogene. 1998 Feb 26; 16(8):997-1007.
    View in: PubMed
    Score: 0.022
  12. A Geometrically-Constrained Mathematical Model of Mammary Gland Ductal Elongation Reveals Novel Cellular Dynamics within the Terminal End Bud. PLoS Comput Biol. 2016 Apr; 12(4):e1004839.
    View in: PubMed
    Score: 0.019
  13. Engineering transgenes for use in the mammary gland. Genet Eng (N Y). 1996; 18:57-81.
    View in: PubMed
    Score: 0.019
  14. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013 Nov 12; 14(11):R125.
    View in: PubMed
    Score: 0.016
  15. Separation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med. 2013 Mar; 2(3):199-203.
    View in: PubMed
    Score: 0.015
  16. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res. 2012 Oct; 21(5):1117-23.
    View in: PubMed
    Score: 0.014
  17. Casein gene expression: from transfection to transgenics. Cancer Treat Res. 1992; 61:379-97.
    View in: PubMed
    Score: 0.014
  18. Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. Dev Biol. 2011 Apr 01; 352(1):116-27.
    View in: PubMed
    Score: 0.013
  19. Genetic manipulation of individual somatic mammary cells in vivo reveals a master role of STAT5a in inducing alveolar fate commitment and lactogenesis even in the absence of ovarian hormones. Dev Biol. 2010 Oct 15; 346(2):196-203.
    View in: PubMed
    Score: 0.013
  20. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3728-33.
    View in: PubMed
    Score: 0.012
  21. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15853-8.
    View in: PubMed
    Score: 0.008
  22. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 2003 Dec 01; 63(23):8256-63.
    View in: PubMed
    Score: 0.008
  23. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res. 2003 Dec; 1(14):1036-47.
    View in: PubMed
    Score: 0.008
  24. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol. 1997 Jun; 17(6):3155-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.